$31.60
+1.25 (+4.12%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+199.4% upside
Low Target
$72.50
Average Target
$94.61
High Target
$144.94
Current Price
$31.60
Current
$31.60
$31.60
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Scenario Analysis
Bear Case
$72.50
129.4%
Low target
Base Case
$94.61
+199.4%
Avg target
Bull Case
$144.94
+358.7%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$56.05
-43.6% from high
52-Week Low
$19.07
+65.7% from low
50-Day SMA
$46.91
-32.6% vs SMA
200-Day SMA
$30.68
+3.0% vs SMA
RSI (14)
41.5
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |